Back to search results

INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use

Abroad (travel likely)Recruiting

Conditions

Systemic Lupus Erythematosus (SLE)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Research Site, Buenos Aires, Argentina

  • Research Site, Córdoba, Argentina

  • Research Site, Guangzhou, China

  • Research Site, Hong Kong, China

  • Research Site, Shenzhen, China

  • Research Site, Zhongshan, China

  • Research Site, Zhuhai, China

  • Research Site, San José, Costa Rica

  • Research Site, Alexandria, Egypt

  • Research Site, Cairo, Egypt

  • Research Site, Guatemala City, Guatemala

  • Research Site, Aktobe, Kazakhstan

  • Research Site, Almaty, Kazakhstan

  • Research Site, Almaty, Kazakhstan

  • Research Site, Astana, Kazakhstan

  • Research Site, Astana, Kazakhstan

  • Research Site, Pavlodar, Kazakhstan

  • Research Site, Semey, Kazakhstan

  • Research Site, Shymkent, Kazakhstan

  • Research Site, Kuwait City, Kuwait

  • Research Site, Mexico City, Mexico

  • Research Site, Mérida, Mexico

  • Research Site, Muscat, Oman

  • Research Site, Doha, Qatar

  • Research Site, ASIR, Saudi Arabia

  • Research Site, Jeddah, Saudi Arabia

  • Research Site, Riyadh, Saudi Arabia

  • Research Site, Kaohsiung City, Taiwan

  • Research Site, Taichung, Taiwan

  • Research Site, Taichung, Taiwan

  • Research Site, Taipei, Taiwan

  • Research Site, Taoyuan, Taiwan

View source on ClinicalTrials.gov(opens in a new tab)